Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions
Authors:
- Mirjana GrujićMGMirjana Grujić
- Metka RenkoMRMetka Renko
- 1 August 2002
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 182 (2) , 113-119
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Increased sensitivity to cis-diamminedichloroplatinum induced apoptosis with mitochondrial DNA depletionCell Death & Differentiation, 1998
- Ubenimex Activates the E‐Cadherin‐mediated Adhesion of a Breast Cancer Cell Line YMB‐SJapanese Journal of Cancer Research, 1995
- The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug ResistanceBiochemical and Biophysical Research Communications, 1995
- Expression of Aminopeptidase N on Human Choriocarcinoma Cells and Cell Growth Suppression by the Inhibition of Aminopeptidase N ActivityJapanese Journal of Cancer Research, 1994
- Purification and characterization of a ubenimex (Bestatin)‐sensitive aminopeptidase B‐like enzyme from K562 human chronic myeloid leukemia cellsFEBS Letters, 1994
- Ubenimex in the treatment of acute nonlymphocytic leukemia in adultsAnnals of Hematology, 1993
- Induction of Multidrug Resistance in Human Cells by Transient Exposure to Different Chemotherapeutic DrugsJNCI: Journal of the National Cancer Institute, 1993
- Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEVNature, 1992
- Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cellsInternational Journal of Immunopharmacology, 1982
- Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)International Journal of Cancer, 1976